P3 Health Partners Inc. (PIII) Fair Value 2026

PIII · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.7 /10

32 fundamental signals · 0 models active

Value Trap Risk

LOW (39/100)

Quick Summary — As of 2026-08-28, P3 Health Partners Inc. (PIII) trades at $9.22. QOC: 4.7/10. Value Trap Risk: 39/100 (LOW). 0/13 models active.

Key Facts

Ticker
PIII
Price
$9.22
Quality Score
4.7/10
Value Trap Risk
39/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 4.7/10 signals weak fundamentals

What Fair Value Does Each Model Give PIII?

0 Intrinsic Value Models vs. Current Price ($9.22)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is P3 Health Partners Inc. (PIII) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, P3 Health Partners Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About PIII?

0 of 13 models are currently active for PIII. See which stocks rank higher →

How Does PIII Rank in Medical Care Facilities?

Among 60 Medical Care Facilities stocks, PIII ranks #52 by Quality of Company score. CirclFi's QOC score of 4.7/10 evaluates 32 fundamental signals. A score of 4.7 reflects mixed fundamentals.

See all Most Undervalued Medical Care Facilities Stocks →

P3 Health Partners Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is PIII a Value Trap?

CirclFi's Value Trap algorithm assigns PIII a score of 39/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for P3 Health Partners Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, P3 Health Partners Inc. is rated at 4.7/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every PIII valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy P3 Health Partners Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

11 related Medical Care Facilities stocks with 13-model coverage

BMGLBasel Medical Group LtdQOC 4.8CMPSCOMPASS Pathways plcQOC 4.5BICXBioCorRx Inc.QOC 4.9HLYKHealthLynked Corp.QOC 4.1SNDASonida Senior Living, Inc.QOC 5.2FOXOFOXO Technologies Inc.QOC 3.9NUTXNutex Health Inc.QOC 8.4LFSTLifeStance Health Group, Inc.QOC 7.2CCMConcord Medical Services Holdings LimitedQOC 6.1ADUSAddus HomeCare CorporationQOC 8.9NHCNational HealthCare CorporationQOC 8.7

Read investment analysis: BMGL · CMPS · BICX · HLYK · SNDA · FOXO · NUTX · LFST · CCM · ADUS · NHC

Which Other Stocks Have a Similar Quality Score to PIII?

7 companies across all industries closest to PIII’s Quality of Company score of 4.7/10.

BESSBimergen Energy CorporationQOC 4.7UPWheels Up Experience Inc.QOC 4.7IBNICICI Bank LimitedQOC 4.7LBRXLB Pharmaceuticals IncQOC 4.7FTHFaeth Therapeutics, Inc.QOC 4.7BDJBlackRock Enhanced Equity Dividend TrustQOC 4.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: BESS · UP · IBN · LBRX · FTH · BDJ · NVDA

Where Does PIII Sit in CirclFi's Medical Care Facilities Rankings?

PIII is ranked against every other Medical Care Facilities stock CirclFi covers in each of these screens.

See all Medical Care Facilities stocks ranked →

What Else Do Investors Ask About P3 Health Partners Inc.’s Valuation?

What is P3 Health Partners Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for P3 Health Partners Inc. (PIII). The Quality of Company score is 4.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is PIII overvalued or undervalued right now?

At $9.22, 0 of 0 active models suggest PIII may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits P3 Health Partners Inc.'s business model in Medical Care Facilities.

What does a Quality of Company score of 4.7 mean for PIII?

P3 Health Partners Inc.'s QOC of 4.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on PIII?

CirclFi analyzes PIII with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is PIII a value trap in 2026?

P3 Health Partners Inc.'s Value Trap score is 39/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns P3 Health Partners Inc. (PIII) a Quality of Company score of 4.7/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/PIII/ · Methodology
Primary sources for this PIII valuation
  • Financial statements: P3 Health Partners Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001832511) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for PIII as of ; valuations recomputed .